Contemporary Mechanical Support Devices for Temporary and Long-Term Applications.

Area of Science:

• Cardiology
• Medical Devices
• Critical Care Medicine

Background:

• Mechanical circulatory support (MCS) has transformed advanced heart failure and cardiogenic shock management.
• Randomized controlled trials (RCTs) show inconsistent mortality benefits with temporary MCS devices, leading to variable institutional outcomes.

Purpose of the Study:

• To examine contemporary MCS devices, including their hemodynamic principles, clinical outcomes, complications, and selection strategies.
• To analyze the disconnect between hemodynamic improvements and mortality benefits in temporary MCS devices.
• To highlight the importance of structured care delivery systems for optimizing MCS outcomes.

Main Methods:

• A narrative review of published literature on MCS clinical applications and outcomes.
• Examination of reference lists to identify additional relevant sources.
• Analysis of data from landmark trials and contemporary studies on temporary and durable MCS devices.

Main Results:

• Temporary MCS devices exhibit a hemodynamic-survival paradox, with improved hemodynamics not translating to mortality benefits in RCTs.
• Factors contributing to this paradox include delayed intervention, device complications, heterogeneous patient selection, and inadequate trial power.
• Third-generation durable MCS devices show improved outcomes, and multidisciplinary shock teams with standardized protocols significantly reduce mortality.

Conclusions:

• Optimal outcomes with MCS require integrating devices into structured care delivery systems, emphasizing comprehensive hemodynamic assessment and multidisciplinary team activation.
• Future directions include implementation science, quality metrics, precision medicine, and trials in phenotype-selected populations with protocolized care.
• A systems-of-care paradigm is crucial for translating technological advances in MCS into sustained mortality reduction.